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Abstract: In this work, we developed a sandwich DNA-immunosensor for quantification of the
methylated tumour suppressor gene O-6-methylguanine-DNA methyltransferase (MGMT), which
is a potential biomarker for brain tumours and breast cancer. The biosensor is based on aminated
reduced graphene oxide electrode, which is achieved by ammonium hydroxide chemisorption
and anti-5-methylcytosine (anti-5mC) as a methylation bioreceptor. The target single-strand (ss)
MGMT oligonucleotide is first recognised by its hybridisation with complementary DNA to form
double-stranded (ds) MGMT, which is then captured by anti-5mC on the electrode surface due to the
presence of methylation. Raman spectroscopy, X-ray photoelectron spectroscopy (XPS) and Scanning
electron microscopy (SEM) techniques were used to characterise the electrode surface. Cyclic voltam-
metry (CV) and differential pulse voltammetry (DPV) techniques were used for electrochemical
measurements. Under optimised conditions, the proposed biosensor is able to quantify a linear
range of concentrations of the MGMT gene from 50 fM to 100 pM with a limit of detection (LOD)
of 12 fM. The sandwich design facilitates the simultaneous recognition and quantification of DNA
methylation, and the amination significantly improves the sensitivity of the biosensor. This biosensor
is label-, bisulfite- and PCR-free and has a simple design for cost-efficient production. It can also be
tailor-made to detect other methylated genes, which makes it a promising detection platform for
DNA methylation-related disease diagnosis and prognosis.
Keywords: reduced graphene oxide (rGO); quantification of DNA methylation; amination; NH2
chemisorption; MGMT gene
1. Introduction
DNA methylation is an epigenetic modification (alterations in gene expressions with-
out changing the sequence) of DNA that plays an important role in regulating cellular
function. It has been shown that changes in DNA methylation patterns may be associated
with various diseases including cancer [1,2]. DNA methylation is the covalent binding
of a methyl group (–CH3) to the 5th carbon atom of a cytosine nucleotide that follows a
guanine nucleotide (CpG sites) [2]. There are different techniques to detect DNA methyla-
tion. Conventional techniques based on molecular biology including bisulfite treatment,
methylation-specific PCR (MSP), mass spectrometry (MS) and liquid chromatography (LC)
have been used extensively [3–5]. These techniques are occasionally used together and
may rely on each other. Despite advantages such as high sensitivity and not being affected
by DNA imperfections, these techniques require expensive equipment, large amounts of
samples and specific expertise and are limited by analysis time, which are disadvantages
when detecting DNA methylation. In recent years, considerable effort has been directed
towards the development of biosensors and DNA sequencing techniques that have the
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potential to overcome the limitations of the aforementioned techniques, along with porta-
bility and amenability to miniaturisation [3]. Biosensors can either be used to detect DNA
methylation on their own or can be combined with conventional techniques [6].
Povedano et al. [7] reported two different electrochemical affinity biosensors to detect
methylated DNA. In the first method, anti-5-methylcytosine (anti-5mC) was used to capture
methylated DNA followed by another antibody conjugated with peroxidase used as the
detector element. In the second method, a capture probe was immobilised on the surface
and was used to hybridise the DNA. After hybridisation, the methyl group was captured by
anti-5mC and a secondary antibody conjugated with peroxidase was used as the detector
element. In the former technique (the immunosensor), the biological reactions took place
on the surface of carboxylic acid-modified magnetic beads (HOOC-MBs), while in the latter
(the DNA sensor), they are placed on Streptavidin-modified MBs (Strep-MBs). In both
of the techniques, MBs were then magnetically captured on a screen-printed electrode
followed by an amperometric detection of the target gene. The limit of detection (LOD)
was reported to be 6.8 pM for the immunosensor with relative standard deviation (RSD)
= 3.9% and 42 pM for the DNA sensor with RSD = 4.8%. Chen et al. [8] reported an
electrochemical stem-loop-tetrahedron composite DNA-probe platform immobilised on
a AuNP-coated gold electrode. After immobilisation of the composite DNA probe on
the electrode surface, complementary DNA was added and hybridisation took place.
Streptavidin-horseradish peroxidase (S-HRP) and an appropriate substrate were used to
amplify the signal. This platform showed a broad dynamic range of 1 aM to 1 pM, and the
LOD was 0.93 aM. Khodaei et al. [9] developed an immunosensor using reduced graphene
oxide (rGO) and anti-5mC to capture methylated DNA, which was then hybridised with
ssDNA-conjugated Fe3O4 nanoparticles. The LOD for this biosensor was reported to
be 9 × 10−5 ng/mL (0.6 fM). Daneshpour et al. [10] developed a chip format sandwich
biosensor for the analysis of DNA methylation using Fe3O4/N-trimethyl chitosan/gold
(Fe3O4/TMC/Au) nanocomposite as the label. In this work, polythiophene (PT) was used
as an immobilisation platform for antibodies. The linear range of concentration for this
biosensor was reported to be 50 fM to 5 nM, and the LOD was 2 fM.
Graphene has beneficial electrical, mechanical and optical properties. It has high mobil-
ity for charge carriers, high electrical conductivity and large surface area (2630 m2/g) [11,12].
Moreover, the electrochemical performance of graphene and its derivatives such as graphene
oxide (GO) and reduced graphene oxide (rGO) are shown to be higher compared to
other electrodes such as glassy carbon (GC), graphite and carbon nano tubes (CNTs) [12].
The electron transfer behaviour of graphene shows well-defined redox peaks using cyclic
voltammetry (CV) in redox active solutions such as [Fe(CN)6]3−/4− and [Ru(NH3)6]3+/2+.
Additionally, the apparent electron transfer constant (k0) is higher in graphene than GC,
indicative of a faster electron transfer [13]. The aforementioned properties along with the
presence of defects, disorders and functional groups on the surface of graphene, GO and
rGO makes them suitable for biosensing platforms [11]. Defects provide active sites for
electron transfer and oxygen-containing functional groups to help in oxidation reactions
by reducing the overpotential voltage [14,15].
Li et al. [16] developed a novel graphene–rGO double layer biosensor for the detec-
tion of a DNA antigen. The reported electrochemical biosensor is label-free and requires
no signal enhancement and complicated immobilisation. The biosensor showed a lin-
ear range from 10−10 to 10−7 M and a limit of detection of 1.58 × 10−13 M (0.158 pM).
He et al. [17] fabricated an electrochemical biosensor based on amine functionalised rGO–
Fe2O3 nanocomposite modified glassy carbon electrode (GCE). This biosensor was used for
the detection of rutin, and CV and second derivative linear sweep voltammetry (SDLSV)
were used to investigate the sensor performance. The linear range was reported to be
6.0 nM to 80 µM with a LOD of 4 nM. Haque et al. [18] reported a DNA–graphene affinity
biosensor for the detection of regional DNA methylation in a collection of DNA samples
taken from cancer cell lines as well as cancer tissues. Their method is based on the ad-
sorption affinity of graphene-modified electrodes towards DNA nuclebases (guanine (G)
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> adenine (A) > thyamine (T) > cytosine (C)). The reported biosensor is able to distin-
guish fully, partially and non-methylated DNA sequences with single CpG resolution and
requires no sequencing analysis.
This paper introduces an immuno-DNA-based electrochemical biosensor for label-free
detection of the MGMT tumor suppressor gene. In this biosensor, reduced graphene oxide
electrodes (rGO) modified with anti-5-methylcytosine antibody (anti-5mC) were used to
capture the antigen. A novel technique is introduced to functionalise the rGO surface with
nitrogen-containing functional groups. Functionalisation of amine groups was achieved
by chemisorption of ammonium hydroxide at the oxygenated and defect sites of the rGO
surface. Raman and XPS techniques confirmed the formation of a layer of N-containing
functional groups, with the amine groups as the dominant group (amination). Amination
facilitates antibody immobilisation, allowing femtomolar concentration to be detected.
This approach can potentially be used to detect any methylated gene that is known as a
disease biomarker. It can be beneficial in point-of-care (POC) programs as an inexpensive
tool because signal enhancing and target labeling are not required.
2. Materials and Methods
2.1. Reagents and Solutions
All of the reagents used in this study were of analytical grade. Tris-EDTA (TE) pH
8.0, phosphate buffered saline (PBS) pH 7.2, bovine serum albumin (BSA), sodium chloride
(NaCl), potassium ferricyanide (K3[Fe(CN)6]), potassium chloride (KCl) and ammonium
hydroxide solution 28% (NH3(aq)) were purchased from Sigma-Aldrich (UK). Recombinant
protein G was obtained from ThermoFisher (UK). PBS tablets, pH 7.4, were purchased
from Fisher Scientific (UK), and the PBS buffer solution was prepared in Milli-Q wa-
ter. Mouse anti-5-methylcytosine monoclonal antibody (anti-5mC) was purchased from
Zymo research (USA). All the synthetic nucleic acids were obtained from Integrated DNA
Technologies (USA). The purchased single-stranded (ss) DNA sequence of the MGMT
oligonucleotide was GTCC CM GA CM GCC CM GCAG GTCCT CM GCGGTGCGCAC-
CGTTTGCGACTTGGTG, where CM was methylcytosine. The complementary sequence
was CACCAAGTCGCAAACGGTGCGCACCGCGAGGACCTGCGGGCGTCGGGAC.
2.2. Apparatus and Measurements
All of the electrochemical measurements were performed using a µStat ECL BiPo-
tentiostat/Galvanostat purchased from Dropsens (Spain). The screen-printed electrodes
(DRP-110RGPHOX) were also obtained from Dropsens. The electrodes had rGO as the
working electrode, carbon as the counter electrode and silver as the reference electrode.
Electrochemical measurements (cyclic voltammetry, CV and differential pulse voltam-
metry, DPV)were carried out for the bare electrode and after each incubation step. The mea-
surements were performed in 100 µL of 10 mM PBS pH 7.4 solution containing 10 mM
K3[Fe(CN)6] and 1M KCl as electrolyte agents. CV scans were obtained over a potential
range of 0.55 and −0.2 V using a scan rate of 100 mV/S. DPV scans were performed over a
potential range of 0.45 and −0.15 V, a pulse duration of 40 ms and a scan rate of 100 mV/s.
All of the measurements were carried out at room temperature.
Raman spectra were obtained using a XPLORA HORIBA system combined with an
Olympus BX41 microscope. A 532 nm green laser source with a power of 100 mW, 100×
objective lens, a scan range of 1100 to 3000 cm−1 and an exposure time of 5–60 s were used
to characterise the electrodes.
A Thermo Scientific Nexsa X-Ray Photoelectron Spectrometer System was used to
carry out XPS analysis using a monochromatic Al Kα X-ray source (1486.68 eV). The pass
energy for wide scans was 200 eV, with an energy step size of 1 eV and 10 scans. The pass
energy for high resolution scans was 40 eV, with an energy step size of 0.1 eV and 20 scans.
Scanning electron microscopy (SEM) was performed using a JEOL 6610LV SEM.
The SEM images of the rGO electrode and the electrode after incubation in ammonium
hydroxide and antibody are provided in the Appendix A (Figure A1).
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2.3. Preparation Steps
In order to immobilise the functional groups that facilitate immobilisation of antibodies
on the surface, the rGO electrodes were first incubated in ammonium hydroxide solution
(28.0–30.0% NH3 basis) for 2 h at room temperature. Subsequently, the aminated electrodes
were dried with nitrogen and were kept in a vacuum for further use.
At the time of experiment, the aminated electrodes were first incubated in a mixture
of anti-5mC and protein G (70:30) both diluted in PBS pH 7.2. Protein G is a bacterial
membrane protein that is commonly used for immobilisation of oriented antibodies [19].
Protein G is known for its affinity to the non-antigenic (Fc) regions of antibodies, leaving the
antigen binding sites available to bind to their target antigen [20–22]. After immobilisation
of antibody and protein G mixture, the unbound functional groups were blocked using
1% BSA in PBS pH 7.4. Finally the sensor was incubated in different concentrations of
ssDNA and hybridised target MGMT oligonucleotides. The electrode was washed with
300 µL of PBS pH 7.4 after each incubation step to remove unbound molecules and after
each measurement to clean the surface and prepare for the next incubation step.
The hybridisation of ssDNA strands was performed as follows: a single-stranded
MGMT target and its complementary strand were first brought to a concentration of 1 µM
using TE buffer containing 50 mM of NaCl (TE-NaCl). Then, 200 µL of each was added
to a vial and the mixture was heated at 65 ◦C for five minutes to facilitate hybridisation.
The mixture was then diluted with TE–NaCl and kept at 4 ◦C for short term use.
Various experimental variables involved in the biosensor preparation were optimised
to achieve the best possible sensitivity and LOD. This includes the optimisation of antibody,
BSA and antigen incubation times as well as application of protein G (with or without protein
G). A detailed description is provided in the Appendix A (Figures A2–A5). The evaluated
variables, the tested ranges and the optimal values are summarised in Table A1. The optimal
conditions were used to perform the linear regression and selectivity studies. A scan rate
experiment was also performed, and the results are provided in Figure A7.
3. Results and Discussion
3.1. Characterisation of the Sensing Electrode
The rGO SPEs were incubated in ammonium hydroxide solution (28.0–30.0% NH3
basis) for 2 h in order to functionalise amine groups on the surface, facilitating binding of
the antibodies to the rGO surface (see Section 2.3). The presence of N-containing functional
groups were confirmed using Raman and XPS.
3.1.1. Raman
Raman spectra of the bare rGO electrode and the aminated electrode are compared in
Figure 1. The strong peak at around 1578 cm−1 represents the in-plane vibrations of sp2-
bonded graphitic carbon atoms (G band), while the weak peak at 1340 cm−1 is attributed
to the out-of-plane vibration of disordered structures (D band) [23]. No shifts were seen
in any of the bands after amination, which means no doping or strain occurred in the
aminated rGO lattice [24–26]. In general, the peak intensity ratio (ID/IG) can be used to
evaluate the ratio of structural defects or disorder level in the rGO layers [23]. The ID/IG
for the bare electrode was 0.6 while it increased to 0.7 for the aminated electrode suggesting
the presence of more defect sites in the aminated rGO sample. These results are consistent
with the results from Wei et al. [27] and Baldovino et al. [28]. Moreover, the full width
at half maximum (FWHM) of the G peak of the Raman spectra is often used along with
the ID/IG ratio and gives further information about the level of defects of the sample [29].
The FWHM of the G peak increased from 60.5 to 78.2 after the amination of rGO samples,
which confirms the presence of N atoms on the surface [28].
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Figure 1. Raman spectra obtained from a bare reduced graphene oxide (rGO) electrode and rGO
electrode incubated in ammonium hydroxide. Both the G (1578 cm−1) and D (1340 cm−1) bands
decreased and broadened after rGO amination while the ID/IG ratio increased from 0.6 to 0.7.
3.1.2. XPS
XPS measurements were carried out to quantitatively characterise the chemical com-
position of the bare and aminated rGO electrodes. Survey scans of the bare and the aminated
rGO as well as C1s and N1s high-resolution scans of these samples are shown in Figure 2.
As can be seen in Figure 2b, a nitrogen peak was observed at 400 eV in the survey scan
of the aminated rGO, which confirms the presence of nitrogen-bearing molecules on the
surface. However, a small N peak in the spectrum of bare rGO (Figure 2a) was also seen,
which is due to the reduction process of graphene oxide [16]. The atomic ratio of nitrogen
was calculated to be 2.09% for aminated rGO, while it was only 0.61% for the bare rGO
sample. The integrated peak areas of N and C were used to calculate the N/C ratio for both
samples. The N/C ratio was 3.07% for the aminated sample and 0.83% for the bare sample.
The N1s spectra showed asymmetrical profiles (Figure 2c,d). These can each be decon-
voluted into two components. The peak located at 399.9 eV can be attributed to C-NH2,
and the one located at 401.8 eV can be assigned to C-NH4+ (quaternary nitrogen) [30–32].
Comparing the N1s spectra before and after amination showed that the C-NH2 peak height
doubled while the C-NH4+ peak height showed no significant change. This shows that
C-NH4+ was already embedded in the rGO lattice during the reduction process while
the amination process only resulted in increasing the amount of NH2 on the surface (see
Section 3.2).
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Figure 2. XPS spectra of rGO and aminated rGO electrodes. Survey scan of a bare rGO electrode (a) and an aminated
electrode (b). N1s high resolution spectra of bare rGO (c) and aminated rGO (d) electrodes and C1s high resolution spectra
of bare rGO (e) and aminated rGO (f) electrodes.
The high resolution C1s spectra also exhibited asymmetrical shapes and tailing peaks
for both aminated rGO and bare rGO samples (Figure 2c,f, respectively). They can each
be deconvoluted into three component peaks. The main component peaks correspond to
the presence of C atoms in C–C bonds (sp3 bonded carbons), located at 284.80 eV for the
rGO sample and at 284.90 eV for the aminated sample [33]. The other component peaks
are located at 286.81 and 286.86 eV for bare and aminated samples, respectively, which can
be attributed to C–O or C–N bonds [30,34]. Finally, the peaks at higher binding energies,
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288.53 and 288.64 eV, for bare and aminated electrodes, respectively, can be assigned to
C=O bonds [35].
3.2. Ammonium Hydroxide Chemisorption
Nitrogen atoms can, in principle, be incorporated onto the surface in three ways. It
can be either by replacing a carbon atom present in the lattice with an N atom, by replacing
an existing functional group by an N containing functional group [28,36] or by binding
to the defect sites and broken C–C bonds present in the rGO flakes [37,38]. Because of
the absence of high temperature and pressure, in this study, it is assumed that the direct
replacement of carbon by nitrogen atoms does not occur. Instead, NH3 is assumed to react
with either defects in the lattice or with acidic sites of rGO that are oxygenated functional
groups, namely, hydroxyl, epoxide and carboxyl groups [28]. Because the rGO SPE is made
of stacked rGO flakes, many defect/vacancy sites are available for the attachment of amine
groups (Figure 3). The presence of defects constitute instabilities of the structure of rGO,
making these sites prone to bonding with ammonia to stabilise the structure [39]. In the
case of reactions with oxygenated functional groups, due to the lack of high temperatures
and suitable activators (e.g., thionyl chloride, carbodiimide or tosyl chloride), the only
feasible reaction is that ammonia attacks epoxide groups as a nucleophile (Figure 3). In this
reaction, a new bond with the carbocation adjacent to the epoxide group will form, resulting
in epoxide opening, dissociation of NH3 and formation of an amino alcohol [38]. Our XPS
experiments confirm that this is the dominant amination process, as shown by the increase
in the C-NH2 component in the N1s high resolution spectra and the increase in the C–O/C–
N component in the C1s spectra while the peak of C=O remained the same (Figure 2f).
The above surface reactions do not affect the structure of rGO, as evidenced by the Raman
spectra (Figure 1), which show that no major defects were introduced after amination.
Figure 3. Schematic of the possible surface reactions that may occur on the rGO electrode after
incubation in ammonium hydroxide. These reactions would lead to the presence of amine functional
groups on the surface.
Besides acting as a linker for antibody, these amine groups can form hydrogen bonds
with adjacent or newly formed oxygen bearing groups such as OH· · ·N and O· · ·HN,
which facilitate electron transfer by acting as electron donors to rGO and stabilise the
structure [37,40].
3.3. Electrochemical Experiments
3.3.1. Electrochemical Behaviour and Selectivity
After each incubation step, the electrochemical response was evaluated via the be-
haviour of voltammograms following structural changes in the biofunctional surface of
the electrode. Figure 4a shows a schematic of the various preparation steps of the biosensor
as well as measured voltammograms for the bare electrode (rGO), aminated electrode, anti-
body, BSA as the blocking agent and antigen for both CV (Figure 4b) and DPV (Figure 4c)
measurement techniques at a scan rate of 100 mV/s.
































































Figure 4. Schematic display of the developed method for the quantification of O-6-methylguanine-DNA methyltransferase
(MGMT) oligonucleotide (a). Electrodes were incubated in ammonium hydroxide and were kept in a vacuum for further
use. Cyclic voltammetry (CV) (b) and differential pulse voltammetry (DPV) (c) characteristics of the sensor after each
assembly steps in 10 mM K3[Fe(CN)6] containing 1 M KCl.
As observed from the CV voltammograms, the anodic peak current (ipa) of the bare
electrode is at 106.5 µA, which is due to the electrical conductivity and electron mobil-
ity of rGO and the available electroactive sites on the surface, which facilitate electron
transfer [16,41]. After treating the electrode surface with ammonium hydroxide, the peak
current decreased to 91.7 µA, which is due to the presence of new functional groups on the
surface. The peak current further decreases to 83.4 µA after immobilisation of antibodies
on the surface, which reduces the number of active sites for electron transfer. The peak
current decreased once more to 55.8 µA after immobilising BSA on the surface, which is ex-
pected as it acts as an inert layer and blocks the surface, impeding electron transfer [42,43].
Finally, when the biosensor is incubated in 100 pM of the target dsDNA, the peak current
rises to 65.6 µA, which can be attributed to ionic conductance and π–π interaction of the
DNA duplex, which leads to increased charge transfer [44]. Although the peak current
increased slightly after DNA incubation, it was still smaller than bare, aminated rGO and
antibody peak currents. Additionally, after immobilisation in the antibody, a slight positive
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shift in the peak potential was observed, which is consistent with spatial blockage of the
surface and impeded electron transfer [45]. The cathodic peak currents (ipc) of the CV
voltammograms showed the same trend as the anodic peak current after each incubation
step, with a corresponding negative shift in the cathodic peak current.
The DPV voltammograms for the various preparation and detection steps were in
agreement with the CV voltammograms. The peak current of the voltammogram for
the bare electrode was 71.7 µA. It decreased to 61.8 µA after incubation in ammonium
hydroxide, followed by another decrease to 45.9 µA after immobilising the antibody on the
surface. The peak current once more decreased to 34.5 µA after the sensor was incubated in
BSA, and finally, it grew to 40 µA due to the presence of the target gene and the formation
of immunocomplexes. In addition, there was a positive shift in the peak potential of the
DPV voltammograms, which is due to the impeded electron transfer.
Selectivity tests were performed using methylated DNA, non-methylated DNA and a
blank sample. The results are provided in the Appendix A (Figure A6). All of the above
measurements were carried out under the same measurement conditions.
3.3.2. Biosensor Linearity
DPV measurements were performed for biosensors incubated in various concentra-
tions of single-stranded and double-stranded MGMT oligonucleotides. The results are
shown in Figure 5, where the normalised peak currents are plotted as a function of the
logarithm of the concentration. The normalised peak current increases with an increase in
the concentration, which is in agreement with the results reported by Povedano et al. [46]
for the MGMT gene.
Best fit linear models and their corresponding R2 values are as follows:
ssMGMT: y = 0.0092 ln(x) + 1.0767 with R2 = 0.9893
dsMGMT: y = 0.0184 ln(x) + 1.0665 with R2 = 0.991
The LOD was calculated using the equation LOD = 3.3σ/m, where σ is the standard
deviation of the DPV response of 16 blank samples and m is the slope of the calibration
curve. For ssDNA, the LOD was 25 fM, and for dsDNA, it was calculated to be 12 fM.
To date, to the best of our knowledge, only two groups reported better LODs for the
detection of DNA methylation, but these groups used nanoparticles (Table A2).
Importantly, these results indicate that the response of the biosensor is different
for single-stranded DNA compared to double-stranded DNA. This is due to the fact
that ssDNA forms a coiled shape while dsDNA makes a stretched helix shape, allowing
electrons to be conducted through the duplex and taking advantage of the π-stacks in the
duplex [47–49].
Due to the usage of hybridisation, the biosensor is selective to the target oligonu-
cleotide when applied to dsDNA, but it is not selective when detecting ssDNA because it
responds to the methyl group regardless of the ssDNA sequence. However, the different
responses of the sensor to dsDNA versus ssDNA can be used to achieve selectivity when ap-
plied to a sample with an unknown mixture of methylated single-stranded oligonucleotides.
When hybridising the unknown mixture using the complementary target and diluting the
sample to obtain various concentrations, the formation of dsDNA (or lack thereof) can
be measured.
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Figure 5. Calibration curves constructed with normalised peak currents of DPV responses as a
function of the logarithm of the concentration of target ssDNA (red) and dsDNA (black). For both
targets, the current increases with increases in concentration. Error bars are the standard deviation of
three replicates.
4. Conclusions
A novel sandwich immuno-DNA biosensor was developed for label-free, rapid and
sensitive detection of MGMT oligonucleotides. The biosensor is based on commercially
available screen-printed reduced graphene oxide (rGO) electrodes that were aminated
using ammonium hydroxide solution. Amination was performed in order to provide
amine functional groups on the surface acting as a linker to immobilise biomolecules.
Raman results suggested the presence of nitrogen atoms on the surface, which were further
confirmed to be C-NH2 groups via XPS. Electrochemical detection of the MGMT oligonu-
cleotide was achieved by hybridising the single-stranded synthetic oligonucleotide with its
complementary sequence and by capturing the methylation with an antibody. Under op-
timal conditions, the biosensor showed a LOD of 12 fM for a double-stranded MGMT
gene without any PCR amplification, bisulfite treatment or labelling. The reproducibility
and stability of the sensor over time still needs to be explored in the future. Addition-
ally, the electrochemical performance of the aminated rGO may still be improved using
elevated temperatures and pressures during ammonium hydroxide incubation. Finally,
the response of the proposed technique in plasma samples needs to be tested in future
studies. The proposed technique can be modified to detect other methylated target genes.
This assay can form the basis for clinical applications in diagnostics and patient monitoring
due to its ability to rapidly detect epigenetic biomarkers, high sensitivity and simplicity.
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Appendix A
Appendix A.1. SEM
Scanning electron microscopy (SEM) was used to characterise the surface of the bare
rGO electrode, the aminated electrode and the aminated electrode after incubation in the
antibody. These SEM images are presented in Figure A1. Figure A1a shows the surface of
a bare rGO electrode. The image shows surface irregularities of 5–10 µm. In comparison,
Figure A1b shows an aminated rGO electrode with a smoother surface. Figure A1c shows
the successful immobilisation of biomolecules on the surface.
A B
C
Figure A1. SEM images of a bare rGO electrode (A), an aminated rGO electrode (B) and aminated
electrodes after incubation in the antibody (C).
Appendix A.2. Optimisation
Various experimental variables were optimised for the purpose of seeking the highest
possible sensitivity of the biosensor. High sensitivity is critical in the quantification of
methylation of the target oligonucleotide due to its presence in only a small subset of
cells in a clinical specimen [50,51]. The relevant experimental steps that were optimised
are antibody, BSA and antigen incubation times as well as the presence of protein G.
Nanomaterials 2021, 11, 985 12 of 18
The evaluated variables, their ranges and the optimal values are summarised in Table A1.
In all of the optimisation tests, the CV and DPV responses of 100 and 1000 pM of target
MGMT oligonucleotides were evaluated to select the optimal conditions. The error bars in
all of the experiments are the standard deviation of three replicates.
Table A1. Optimised preparation steps and selected values.
Experimental Variable Range Selected Value
Application of protein G With-without protein G With protein G
Anti-5mC incubation time, hours 1–8 4
BSA incubation time, hours 5–30 15
MGMT gene incubation time, hours 30–120 60
The first optimisation step was understanding the effect of protein G functionality.
For this, the sensor was incubated with the antibody conjugated and without being con-
jugated to protein G. As shown in Figure A2, using protein G decreased the error bars
compared to not using protein G and the target concentrations, leading to enhancement in
distinguishability for the biosensors as the error bars of both concentrations do not overlap.
These results are due to the fact that the presence of protein G acts to preferentially align
the antibodies on the electrode surface, resulting in an increased antigen-binding capacity
of the antibody (Elshafey et al. [19]).
BSA incubation time was optimised by incubating three groups of electrodes in
BSA for either 5, 15 or 30 min. The results (Figure A3) showed that, among these three,
an incubation time of 15 min was optimal, as the error bars are the smallest and the increase
in the normalised peak current between 100 and 1000 pM in both techniques are consistent.
In contrast, the normalised peak currents for both 15 and 30 min of the BSA incubation time
showed larger error bars, which can be due to the remaining unbound functional groups at
the shorter 5 min incubation time, and conversely, saturation of the electrode surface with
BSA molecules for the longer 30 min incubation time. Therefore, the incubation time of 15
min for BSA was selected as the incubation time in further studies.
A B
Figure A2. Detection of 100 (purple) and 1000 (blue) pM of the target gene using either the antibody
or antibody conjugated to protein G, using both CV (A) and DPV (B) techniques.
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A B
Figure A3. Detection of 100 (purple) and 1000 (blue) pM of the target gene with various bovine serum
albumin (BSA) optimisation times (5, 15 and 30 min), using both CV (A) and DPV (B) techniques.
The antibody incubation time was optimised by incubation of the electrodes in the
antibody for 1, 2, 3, 4, 5, 6 or 8 h. Figure A4 shows that the optimal incubation time
was 4 h, resulting in very small, non-overlapping error bars between 100 and 1000 pM.
Additionally, the normalised peak current shift as well as the error bars were consistent
in both measurement techniques in all incubation times. However, in shorter incubation
times (1, 2 and 3 h), there was a small shift between 100 and 1000 pM, which shows that the
sensor is unable to distinguish between these two concentrations. Additionally, for longer
incubation times (5, 6 and 8 h), the error bars are larger, meaning that the result of the
biosensor is not reproducible. Hence, 4 h incubation time was selected as the optimised
antibody incubation time.
In order to optimise the antigen incubation time, the sensors were incubated with the
antigen for 30, 60, 90 or 120 min. The results for this experiment are shown in Figure A5. These
results show that, although there was a shift between 100 and 1000 pM in all of the groups,
the error bars were large and overlapped in almost all of the cases except for the group that
was incubated in antigen for 60 min. Consequently, 60 min was chosen as the optimised
incubation time for the antigen.
A B
Figure A4. Detection of 100 (purple) and 1000 (blue) pM of the target gene of the target gene with
various antibody incubation times (1, 2, 3, 4, 5, 6 and 8 h) using both CV (A) and DPV (B) techniques.
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A B
Figure A5. Detection of 100 (purple) and 1000 (blue) pM of the target gene of the target gene with
various antigen incubation times (30, 60, 90 and 120 min) using both CV (A) and DPV (B) techniques.
Appendix A.3. Selectivity
In order to investigate the selectivity of the proposed biosensor protocol, the biosensors
were incubated in blank samples as well as 100 pM of single-stranded methylated and non-
methylated targets and the response was measured with both the CV and DPV techniques.
The blank sample was the buffer and the non-methylated oligonucleotide had the same
sequence as the methylated MGMT oligonucleotide, with no methylation sites. The results
(Figure A6) show that there is a significant difference after incubation in methylated
DNA while no such difference is observed after incubation of the sensor in blank and
non-methylated DNA. This test therefore shows that the proposed biosensor is selective
towards the methyl groups on the methylated gene.
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Figure A6. Comparison of the responses obtained from various targets (methylated, non-methylated
and blank) using the proposed biosensor. Normalized CV peak current for different samples
measured on three different replicas (A). CV (B) and DPV (C) voltammograms of one replica for
each sample.
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Appendix A.4. Scan Rate Experiment
The scan rate experiments of an aminated rGO electrode were performed in PBS pH
7.0 containing 10 mM [Fe(CN)6] and 1 M KCl in order to study the redox reactions on
the surface. Figure A7a shows the effect of varying the scan rate (0.025 to 0.3 V/s) on the
voltammograms of the aminated rGO electrode, where the magnitudes of both the anodic
(Epa) and cathodic (Epc) peak currents increase linearly with the increase in the square
root of the scan rate (Figure A7b). This suggests that the electrochemical reaction is a
diffusion-controlled process [44]. The diffusion coefficient (D) of the redox couple from the
electrolyte to the aminated electrode was calculated using Randles–Sevcik equation [52]:
Ip = (2.69 × 105)n3/2 AD1/2Cv1/2 (A1)
where Ip is the peak current of the aminated electrode (in A), n is the number of electrons
involved (n = 1), A is the surface area of the electrode (in cm2, A = 0.126 cm2), D is the
diffusion coefficient, C is the concentration of the redox species (in mM, C = 10 mM) and v
is the scan rate (in V/s, v = 0.1 V/s, which was used throughout the paper). D is therefore
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Figure A7. CV voltammograms of the aminated electrode under various scan rates from 0.025 V/s
to 0.3 V/s (0.025, 0.05, 0.075, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.275 and 0.3 V/s) (A). Anodic and
Cathodic peaks as a function of the square root of the scan rate (B) and the scan rate (C).
The anodic and the cathodic peak potentials as well as the peak to peak separation
(potential peak shifts, ∆Ep = Epa−Epc) increase with the scan rate (Figure A7c). Redox
couples in which the peak to peak separations show a linear relationship with the scan rate
are categorised as quasi-reversible reactions [53], and it is an indication of facile charge
transfer kinetics in the scan rate range [44]. Therefore, the aminated electrodes provide
adequate accessibility to electrons in transferring between the antibody and the aminated
electrode. The effective heterogeneous electron transfer rate constant (Ks) was calculated
using the Lavrion model [44]:
Ks = mnFv/RT (A2)
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where m is the peak to peak separation (in V, m = 0.362 V), n is the number of electrons
involved (n = 1), F is the Faraday constant (96,485 J/mol), v is the scan rate (in V/s,
v = 0.1 V/s), R is the gas constant (8.314 J/mol.K) and T is room temperature (298 K).
The Ks value was calculated to be 1.41 s−1 at 0.1 V/s, which indicates fast electron transfer
between the amine groups and the rGO electrode.
Appendix A.4.1. Comparison with Other Works
The various parameters of the proposed biosensor are compared with other elec-
trochemical affinity techniques reported so far for the detection of DNA methylation in
Table A2.
Table A2. An overview of the electrochemical affinity biosensor to date for the detection of
DNA methylation.
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